To benefit our clients, we regularly collaborate with PinneyAssociates, experts in abuse potential assessment, and clinical and regulatory strategy for CNS-active drugs and drug products, on study needs and designs, and regulatory filings.
Dr Chris Atterwill
Dr Chris Atterwill is an internationally recognised Toxicologist whose specialist areas include neurotoxicology, endocrine toxicology, novel in vitro systems for toxicity testing and Preclinical Lead Optimisation (PLOT) strategies for Drug Safety Assessment.
Chris has worked in and held senior positions across both pharma and academia and is also a UK Registered Pharmacist with the General Pharmaceutical Council & Fellow of the Royal Pharmaceutical Society.
Chris first qualified as a Pharmacologist at London and Oxford Universities, and having held several MRC Fellowships was appointed GSK Professor & Head of Biosciences at the University of Hertfordshire (UH). At UH Chris established the CellTox Centre and his group was one of the first to develop brain, liver and thyroid spheroid organotypic test systems for xenobiotic toxicity testing. For this work he was awarded Fellowship of the Royal College of Pathologists and Institute of Biology,
He then moved to pharma in roles as Head of Investigative Toxicology and PreClinical Drug Safety before becoming Director of Biosciences and Toxicology at a major CRO. In parallel with the latter roles, Chris served for 8 years on the UK Home Office APC (Animal Procedures Committee) as well as holding positions on the British Toxicology Society Executive Committee, FRAME (Fund for the Replacement of Animals in Medical Experiments) and ECVAM (European Center for the Validation of Alternative Methods) committees and as a Visiting Professor at University of the West of England (UWE). From 2003 Chris was founder & Executive Director of Prognus Ltd.
Chris has a broad experience across Investigative and Regulatory Toxicology & Pathology, Agrochemical & Drug Preclinical Safety Assessment. He has published four books, over 110 peer reviewed publications and presented more than 350 invited lectures and posters at international scientific symposia in the fields of pharmacology and toxicology.